Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (411-420 of 587) with videos related to

Pageof 59
Sort By:
Blood|November 13, 2019
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosisMarco Basset, Irene Defrancesco, Paolo Milani, et al.
Scientific Reports|April 29, 2016
Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidosesNatalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 20, 2009
Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in SwedenOle B Suhr, Oluf Andersen, Thomas Aronsson, et al.
Transplantation|December 24, 2011
Further evidence for amyloid deposition in clinical pancreatic islet graftsGunilla T Westermark, Alberto M Davalli, Antonio Secchi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 11, 2011
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosisGiovanni Palladini, Alessandra Barassi, Stefano Perlini, et al.
Antioxidants & Redox Signaling|January 31, 2017
Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial DamageLuisa Diomede, Margherita Romeo, Paola Rognoni, et al.
Structure (London, England : 1993)|June 22, 2026
Multifaceted effects of N-glycosylation on amyloidogenic κ light chains in AL amyloidosisSarita Puri, Valentina Speranzini, Monica Russo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2015
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosisFrancesca Lavatelli, Esther Imperlini, Stefania Orrù, et al.
British Journal of Haematology|June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemicEfstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring systemLuca Baldini, Maria Goldaniga, Andrea Guffanti, et al.
Pageof 59

Showing results (411-420 of 587) with videos related to

Sort By:
Pageof 59
Blood|November 13, 2019
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosisMarco Basset, Irene Defrancesco, Paolo Milani, et al.
Scientific Reports|April 29, 2016
Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidosesNatalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 20, 2009
Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in SwedenOle B Suhr, Oluf Andersen, Thomas Aronsson, et al.
Transplantation|December 24, 2011
Further evidence for amyloid deposition in clinical pancreatic islet graftsGunilla T Westermark, Alberto M Davalli, Antonio Secchi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 11, 2011
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosisGiovanni Palladini, Alessandra Barassi, Stefano Perlini, et al.
Antioxidants & Redox Signaling|January 31, 2017
Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial DamageLuisa Diomede, Margherita Romeo, Paola Rognoni, et al.
Structure (London, England : 1993)|June 22, 2026
Multifaceted effects of N-glycosylation on amyloidogenic κ light chains in AL amyloidosisSarita Puri, Valentina Speranzini, Monica Russo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2015
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosisFrancesca Lavatelli, Esther Imperlini, Stefania Orrù, et al.
British Journal of Haematology|June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemicEfstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring systemLuca Baldini, Maria Goldaniga, Andrea Guffanti, et al.
Pageof 59